BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38497124)

  • 1. Comparison of normocalcemic versus hypercalcemic primary hyperparathyroidism in a hypercalciuric renal stone population.
    Halimi C; Bor C; Chieze R; Saint-Jacques C; Périé S; Wagner I; Talbot JN; Montravers F; Letavernier E; Buob D; Daudon M; Frochot V; Haymann JP
    J Clin Endocrinol Metab; 2024 Mar; ():. PubMed ID: 38497124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
    Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How should we define cure after parathyroidectomy for normocalcemic primary hyperparathyroidism? A retrospective cohort study.
    Cano-Valderrama O; Ochagavía S; Sanabria C; Familiar C; Díaz J; Picazo S; Sáez-Carlin P; Torres AJ
    Updates Surg; 2021 Dec; 73(6):2293-2299. PubMed ID: 34097295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone.
    Maruani G; Hertig A; Paillard M; Houillier P
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4641-8. PubMed ID: 14557434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level.
    Chertok Shacham E; Maman N; Lazareva T; Masalha R; Mahagna L; Sela G; Ishay A
    Front Endocrinol (Lausanne); 2023; 14():1152464. PubMed ID: 37065752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characteristics and clinical manifestation of normocalcemic primary hyperparathyroidism.
    Yankova I; Lilova L; Petrova D; Dimitrova I; Stoynova M; Shinkov A; Kovatcheva R
    Endocrine; 2024 Mar; ():. PubMed ID: 38489132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone Levels.
    Lui MS; Clemente-Gutierrez U; Vodopivec DM; Chang SL; Shirali AS; Huang BL; Chiang YJ; Fisher SB; Grubbs EG; Guise TA; Graham PH; Perrier ND
    World J Surg; 2023 Feb; 47(2):363-370. PubMed ID: 36195677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?
    Traini E; Bellantone R; Tempera SE; Russo S; De Crea C; Lombardi CP; Raffaelli M
    Langenbecks Arch Surg; 2018 May; 403(3):317-323. PubMed ID: 29541851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
    Pierreux J; Bravenboer B
    Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How useful is an oral calcium load test for diagnosing recurrent calcium stone formers?
    Tostivint IN; Castiglione V; Alkouri R; Bertocchio JP; Inaoui R; Daudon M; Dousseaux MP; Cavalier E; Pieroni L; Izzedine H
    Urolithiasis; 2022 Oct; 50(5):577-587. PubMed ID: 35994082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Normocalcemic primary hyperparathyroidism].
    Spivacow FR; Sapag Durán A; Zanchetta MB
    Medicina (B Aires); 2014; 74(6):457-61. PubMed ID: 25555006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative utility of preoperative imaging in normocalcemic versus hypercalcemic primary hyperparathyroidism.
    Montgomery KB; Gillis A; Ramonell KM; Fazendin JM; Lindeman B; Chen H
    Am J Surg; 2023 Feb; 225(2):293-297. PubMed ID: 36175194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired physical function and evaluation of quality of life in normocalcemic and hypercalcemic primary hyperparathyroidism.
    Voss L; Nóbrega M; Bandeira L; Griz L; Rocha-Filho PAS; Bandeira F
    Bone; 2020 Dec; 141():115583. PubMed ID: 32795678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
    Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
    BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of parathyroidectomy on renal stone recurrence.
    Charles PY; Letavernier E; Périé S; Gauthé M; Daudon M; Haymann JP
    Urolithiasis; 2021 Aug; 49(4):327-334. PubMed ID: 33420577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normocalcemic Hyperparathyroidism.
    Corbetta S
    Front Horm Res; 2019; 51():23-39. PubMed ID: 30641527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.
    Sho S; Kuo EJ; Chen AC; Li N; Yeh MW; Livhits MJ
    Ann Surg Oncol; 2019 Feb; 26(2):539-546. PubMed ID: 30406488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRABECULAR BONE SCORE IN PATIENTS WITH NORMOCALCEMIC HYPERPARATHYROIDISM.
    Díaz-Soto G; de Luis Román D; Jauregui OI; Briongo L; Romero E; Pérez-Castrillón JL
    Endocr Pract; 2016 Jun; 22(6):703-7. PubMed ID: 26866705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normocalcemic versus Hypercalcemic Primary Hyperparathyroidism: More Stone than Bone?
    Amaral LM; Queiroz DC; Marques TF; Mendes M; Bandeira F
    J Osteoporos; 2012; 2012():128352. PubMed ID: 22545220
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.